Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization

Biomacromolecules. 2006 Oct;7(10):2722-7. doi: 10.1021/bm060065f.

Abstract

Several novel functionalized graft copolymer nanoparticles consisting of chitosan (CS) and the monomer methyl methacrylate (MMA), N-dimethylaminoethyl methacrylate hydrochloride (DMAEMC), and N-trimethylaminoethyl methacrylate chloride (TMAEMC), which show a higher solubility than chitosan in a broader pH range, have been prepared by free radical polymerization. The nanoparticles were characterized in terms of particle size, zeta potential, TEM, and FT-IR. These nanoparticles were 150-280 nm in size and carried obvious positive surface charges. Protein-loaded nanoparticles were prepared, and their maximal encapsulation efficiency was up to 100%. In vitro release showed that these nanoparticles provided an initial burst release followed by a slowly sustained release for more than 24 h. These graft copolymer nanoparticles enhanced the absorption and improved the bioavailability of insulin via the gastrointestinal (GI) tract of normal male Sprague-Dawley (SD) strain rats to a greater extent than that of the phosphate buffer solution (PBS) of insulin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biotechnology / methods*
  • Chitosan / chemistry*
  • Choline / analogs & derivatives
  • Choline / chemistry
  • Drug Delivery Systems*
  • Insulin / chemistry
  • Male
  • Methacrylates / chemistry
  • Methylmethacrylate / chemistry
  • Nanoparticles / chemistry*
  • Nanotechnology / methods
  • Polymers / chemistry*
  • Rats
  • Rats, Sprague-Dawley
  • Transplants

Substances

  • Insulin
  • Methacrylates
  • Polymers
  • choline methacrylate
  • Methylmethacrylate
  • Chitosan
  • diethylaminoethyl methacrylate
  • Choline